Morphine Urine Drug Test is a lateral-flow immunochromatographic assay engineered for the qualitative detection of morphine and its primary glucuronide metabolites in human urine specimens. Morphine is the principal active metabolite of heroin (diacetylmorphine) and a widely prescribed opioid analgesic (e.g., MS Contin, Kadian). Urine screening for morphine serves a dual critical function: (1) monitoring patient compliance in chronic pain management and opioid substitution therapy, and (2) detecting illicit heroin use in workplace, forensic, and rehabilitation settings.
Critical Application Scenarios for Morphine/Opiate Testing:
· Pain Management & Palliative Care – Monitor patients prescribed long-term opioid therapy to detect unauthorized drug use or diversion, ensuring compliance with treatment agreements and reducing overdose risk.
· Opioid Substitution Programs (Methadone/Buprenorphine) – Verify abstinence from illicit heroin/morphine use during maintenance therapy, supporting recovery progress.
· Workplace Drug Screening – Essential for safety-sensitive industries (transportation, heavy machinery, construction, oil/gas) where opioid-induced impairment poses severe accident risks.
· Emergency & Clinical Toxicology – Rapidly identify opioid intoxication in patients presenting with miosis, respiratory depression, or altered consciousness-guiding naloxone administration and critical care decisions.
· Law Enforcement & Corrections – On-site screening for probation/parole compliance and drug-influenced driving investigations.
· Rehabilitation & Detoxification Centers – Track treatment progress and detect early relapse to intervene promptly.
Choose our Morphine Urine Drug Test for accurate, defensible, and operationally convenient opiate screening-supporting both clinical integrity and workplace safety in an era of opioid epidemic awareness.
|
Product name |
Morphine Rapid Test Self-Test |
|
Item type |
MOP-U101 |
|
Specimens |
Urine |
|
Shelf life |
2 years |
|
Test Time |
Waiting about 5 minutes |
|
Certificate |
CE, ISO:13485 |
|
OEM |
Acceptable |
|
Storage condition |
The kit should be stored at 2-30°C |
SUMMARY
PRINCIPLE
FAQ
Q: What cut-off level do you use for the Morphine urine test, and can it be customized?
A: Our standard cut-off is 300 ng/mL, consistent with SAMHSA and European guidelines for morphine/heroin metabolite screening. We offer customizable cut-off concentrations-for example, 200 ng/mL for enhanced sensitivity in certain research settings, or 2000 ng/mL for high-threshold forensic/legal protocols. Please specify your target application and regional requirements, and we will tailor accordingly.
Q: Does this test cross-react with codeine or other prescription opioids?
A: Our test employs highly specific monoclonal antibodies optimized for morphine detection. While codeine (a methylated morphine analog) may show moderate cross-reactivity (typically 10–20% at equivalent concentrations) due to structural similarity-which is expected in clinical practice, as codeine is metabolized to morphine-we see minimal cross-reactivity with hydrocodone, oxycodone, methadone, fentanyl, and buprenorphine (<0.1%). We provide a detailed cross-reactivity table with each product batch for your verification and documentation.
Q: How is this test different from a general "Opiates" immunoassay?
A: While general opiate screens often target multiple opiates (morphine, codeine, etc.) with a broader antibody spectrum, our Morphine-specific test is engineered with antibodies that primarily recognize the morphine molecule and its glucuronide conjugates. This makes it ideal for programs specifically monitoring heroin use or morphine-based medication compliance, where distinguishing morphine from other semi-synthetic opioids (e.g., oxycodone) is less critical. For multi-opiate needs, we offer combination panels (MOP + OXY + MTD + FYL + BUP) in a single device.
Q: What is the detection window for morphine/heroin in urine?
A: Morphine and its metabolites are typically detectable in urine for 2–4 days after last use of heroin or oral morphine, depending on dosage, metabolic rate, hydration, and frequency of use. Chronic heavy users may have extended detection windows up to 5–7 days. This provides a robust look-back period for workplace screening, rehabilitation monitoring, and pain management compliance, significantly longer than blood or saliva testing.
Q: What documentation do you provide for regulatory compliance in international markets?
A: We supply a comprehensive regulatory package including: batch-specific Certificate of Analysis (COA) , real-time and accelerated stability reports, cross-reactivity and interference studies, detailed IFU (Instruction For Use) in multiple languages, and CE/FDA/ISO13485 certification documents. For distributors entering regulated markets, we also provide technical file summaries and audit support materials to facilitate customs clearance and local registration across the EU, USA, Middle East, Southeast Asia, and Latin America.
Hot Tags: morphine urine drug test, China morphine urine drug test manufacturers, suppliers, factory, MOP Rapid Test, mop test, Morphine MOP Rapid Test, Morphine Rapid Test, Morphine Test
